A Call for a Rational Polypharmacy Policy: International Insights From Psychiatrists
Open Access
- 25 November 2021
- journal article
- research article
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 18 (11), 1058-1067
- https://doi.org/10.30773/pi.2021.0169
Abstract
Objective Recently, rational polypharmacy approaches have been proposed, regardless of the lower risk and cost of monotherapy. Considering monotherapy as first-line treatment and polypharmacy as rational treatment, a balanced attitude toward polypharmacy is recommended. However, the high prevalence of polypharmacy led the Japanese government to establish a polypharmacy reduction policy. Based on this, the association between the policy and psychiatrists' attitude toward polypharmacy has been under debate. Methods We developed an original questionnaire about Psychiatrists' attitudes toward polypharmacy (PAP). We compared the PAP scores with the treatment decision-making in clinical case vignettes. Multiple regression analyses were performed to quantify associations of explanatory variables including policy factors and PAP scores. The anonymous questionnaires were administered to psychiatrists worldwide. Results The study included 347 psychiatrists from 34 countries. Decision-making toward polypharmacy was associated with high PAP scores. Multiple regression analysis revealed that low PAP scores were associated with the policy factor (beta=-0.20, p=0.004). The culture in Korea was associated with high PAP scores (beta=0.34, p<0.001), whereas the culture in India and Nepal were associated with low scores (beta=-0.15, p=0.01, and beta=-0.17, p=0.006, respectively). Conclusion Policy on polypharmacy may influence psychiatrists' decision-making. Thus, policies considering rational polypharmacy should be established.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP17dk0307047, JP19dk0307073, JP18dk0307075, JP19dm0107095)
- Japan Society for the Promotion of Science (JP15K15431, JP16H06403, JP16H03741, JP19K21591, JP20K16647)
This publication has 15 references indexed in Scilit:
- Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacyPsychiatry Research, 2016
- Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2015
- History, background, concepts and current use of comedication and polypharmacy in psychiatryInternational Journal of Neuropsychopharmacology, 2013
- Antipsychotic polypharmacy: A Japanese survey of prescribers' attitudes and rationalesPsychiatry Research, 2013
- Polypharmacy in psychiatry: A reviewMens Sana Monographs, 2013
- The effect of a smoke-free campus policy on college students' smoking behaviors and attitudesPreventive Medicine, 2011
- Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behaviorSchizophrenia Research, 2011
- Polypharmacy: When Is It Rational?Journal of Psychiatric Practice, 2007
- Using case vignettes to measure HIV-related stigma among health professionals in ChinaInternational Journal of Epidemiology, 2006
- Psychopharmacology: Rational and Irrational PolypharmacyPsychiatric Services, 2001